Corcept Therapeutics (CORT) PT Raised to $45 at Ladenburg Thalmann

August 4, 2022 6:43 AM EDT
Get Alerts CORT Hot Sheet
Price: $23.26 +1.39%

Rating Summary:
    9 Buy, 6 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 21 | New: 16
Join SI Premium – FREE
Ladenburg Thalmann analyst Matt Kaplan raised the price target on Corcept Therapeutics (NASDAQ: CORT) to $45.00 (from $35.00) while maintaining a Buy rating.

You May Also Be Interested In

Related Categories

Analyst PT Change